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Randall W King1, Timothy J Mitchison1,3 and Stuart L Schreiber1,2
Background: Understanding the molecular mechanisms of complex cellular
processes requires unbiased means to identify and to alter conditionally gene
products that function in a pathway of interest. Although random mutagenesis
and screening (forward genetics) provide a useful means to this end, the
complexity of the genome, long generation time and redundancy of gene
function have limited their use with mammalian systems. We sought to
develop an analogous process using small molecules to modulate
conditionally the function of proteins. We hoped to identify simultaneously
small molecules that may serve as leads for the development of
therapeutically useful agents. 
Results: We report the results of a high-throughput, phenotype-based screen
for identifying cell-permeable small molecules that affect mitosis of mammalian
cells. The predominant class of compounds that emerged directly alters the
stability of microtubules in the mitotic spindle. Although many of these
compounds show the colchicine-like property of destabilizing microtubules,
one member shows the taxol-like property of stabilizing microtubules. Another
class of compounds alters chromosome segregation by novel mechanisms that
do not involve direct interactions with microtubules.
Conclusions: The identification of structurally diverse small molecules that
affect the mammalian mitotic machinery from a large library of synthetic
compounds illustrates the use of chemical genetics in dissecting an essential
cellular pathway. This screen identified five compounds that affect mitosis
without directly targeting microtubules. Understanding the mechanism of
action of these compounds, along with future screening efforts, promises to
help elucidate the molecular mechanisms involved in chromosome
segregation during mitosis.
Introduction
High-throughput, phenotypic (based on observable
material or behavioral properties) screening of small mol-
ecules in cells provides a powerful means to interface
synthetic organic chemistry and cell biology. Because
these assays can report on an overall cellular state, they
provide an unbiased, system-based approach to explor-
ing cellular pathways and processes. This situation
differs from typical drug-screening efforts aimed at alter-
ing the function of a single, pre-selected target protein
without immediate concern for the effect of compounds
within cells. The approach described here emulates the
logic of a classical (forward) genetic screen [1], but
differs from genetics in that it relies upon small mol-
ecules, rather than mutations, to modulate conditionally
the circuitry of biological processes [2,3] (see also
http//www-schreiber.chem.harvard.edu/).
We applied this chemical genetic approach to an essential
cellular process, seeking to identify small molecules that
alter the progression of cells through the mammalian cell-
division cycle. In particular, we focused on those pathways
essential to chromosome segregation during mitosis
(Figure 1a) [4–8]. Compounds were initially screened
using a high-throughput cytoblot assay, in which an anti-
body is used to detect a post-translational modification
characteristic of the process of interest (Figure 1b) [9].
This assay used TG-3, a monoclonal antibody (mAb) that
recognizes a form of the protein nucleolin specifically
phosphorylated during mitosis, to report indirectly on the
progress of cells through mitosis [10–12]. Accordingly,
small molecules that increase the reactivity of this mAb in
cells are likely to cause the arrest of cells in the mitotic
state (e.g., [13]). As many compounds that have previously
been shown to arrest cells in mitosis directly affect the
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polymerization of α and β tubulin (the heterodimeric sub-
units of microtubules), and thereby alter the microtubule
dynamics of the mitotic spindle [14,15] (Figure 1a), com-
pounds that scored positively in this initial assay were sub-
sequently tested in an in vitro tubulin polymerization assay
(Figure 1b). To classify further compounds on the basis of
their phenotypic effects, fluorescence microscopy was used
to visualize the distribution of microtubules, actin and
chromatin in cells treated with compounds of interest.
Results
Two rounds of screening of a 16,320 compound library
(Diverse E set, Chembridge Corp.) at ~20–50 µM resulted
in the identification of 139 compounds that increased
(at least 2.5 times) the amount of phosphorylated nucle-
olin in asynchronous A549 lung epithelial cells, as mea-
sured by reactivity of the TG-3 mAb [9]. The structure of
each of the 139 compounds, along with an approximate
estimation of their potency, will be posted on our website
at http://iccb.med.harvard.edu. An example of these data
is shown in Figure 2a and b. These 139 compounds had no
effect on the in vitro polymerization of actin (J. Peterson,
unpublished observations), the in vitro degradation of a
cyclin B–luciferase fusion protein in Xenopus extracts
(R.W.K., unpublished observations) or the activation of a
growth-factor-dependent reporter gene (B. Stockwell,
unpublished observations), suggesting some level of
specificity in their target interactions.
The ability of the 139 compounds to affect directly the
polymerization of purified bovine brain tubulin was
assessed using an in vitro tubulin polymerization assay.
As summarized in Figure 2c, 52 compounds (group I)
destabilized microtubules (data not shown) and one 
compound (group II) stabilized microtubules when
assayed in this format. The remaining 86 compounds
(group III) had no observable effect, and therefore
appear to interfere with progression through mitosis by
mechanisms not involving modulation of microtubule
polymerization dynamics (see below).
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Figure 1
Screening for small molecules that affect the
progression of mammalian cells through
mitosis. (a) Cell-cycle events involved in
mitotic chromosome segregation. Cellular
states linked by a red arrow show increased
reactivity with the TG-3 mAb [11].
(b) Overview of the cytoblot assay and
screening steps for identification of
colchicine-like, taxol-like and other small
molecules that perturb mitosis. See
http://www-schreiber.chem.harvard.edu/
shockwave/cytoblot.html for more details. 
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Group I: colchicine-like small molecules that destabilize
microtubules
On the basis of their effectiveness in the cytoblot assay,
the most potent antimitotic compounds identified are
those compounds that destabilized microtubules in vitro
(group I). These compounds include members of struc-
tural types 1–8 (Figure 3a). Compound 1a is a well-
known microtubule-destabilizer, nocodazole [14]. This
compound was twice present within the library, as was
analog 1b. 
The same three-ring skeleton is shared by six out of the
52 group I compounds (2a–f), although their dose
response in the cytoblot assay varied (Figure 3a). This
variation provided an opportunity to correlate the results
obtained from the cytoblot and tubulin polymerization
assays with the cellular effects of each compound. Cells
were treated with compounds at a given concentration
(see Figure 4), fixed, and the distribution of microtubules
and chromatin was visualized using fluorescence
microscopy (Figure 5). Compounds with effective con-
centrations required for half-maximal signal (EC50) in the
range of 0.5–1.0 µM in the cytoblot assay (e.g. 2b,
Figure 4b) completely destabilized microtubules in both
interphase (e.g., Figure 5d) and mitotic (data not shown)
cells, resulting in randomly arrayed mitotic chromosomes.
Compounds having an EC50 in the range of 5–10 µM (e.g.
2e) either partially destabilized interphase microtubules
or had no visible effect on the microtubule cytoskeleton
(data not shown). Regardless of their effects on inter-
phase cells, these less potent compounds still caused
abnormal mitotic spindle structures and altered chromo-
some distribution. 
Fluorescence microscopy of cells treated with high con-
centrations (~50 µM) of 23 structural analogs of 2
(Diverse E set, Chembridge Corp.), which either scored
negatively in the cytoblot assay or were not within group
I, identified an additional 11 small molecules (2g–q) that
destabilized microtubules in cells (Figure 3a). As com-
pounds 2g, 2i, 2o and 2q were among those considered to
be in group III, these compounds define a subset of
group III that may also directly target tubulin, but may
bind weakly and thus may be ineffective at targeting
purified tubulin in an in vitro assay. For example,
although compound 2g had no effect on the stability of
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Figure 2
Example and summary of screening data for small molecules that
perturb the mitotic machinery of mammalian cells. Compounds
(~50 µM) were pin-transferred into wells of a 384-well plate containing
50 µl media and ~4000 cells. After a 24 h incubation, cells were fixed
and processed for a TG-3 cytoblot assay as described previously [9].
(a) Results of a TG-3 cytoblot assay on 314 of the 16,320
compounds screened. (b) Five compounds (I–V) were chosen from
within this set and the values of their maximum fold-activation in TG-3
mAb reactivity (relative to a DMSO control) after retesting at ~100 µM
are in green. As a positive control, column 1, rows 1–8 contained
nocodazole (332 nM) and as a negative control, column 1, rows 9–16
received an equivalent concentration of DMSO. (c) Summary of
complete screen showing the division of the initial 139 positive
compounds (0.85 % of compounds screened) into three functional
groups reflecting their effect on microtubule stability measured in vitro
with purified bovine brain tubulin. Of the compounds picked in the first
round 81% retested as positives in the second round. Compounds I–V
all fell within group I. Compounds within group III were considered as
candidates for mitosis-specific inhibitors that function through
mechanisms not involving direct interaction with microtubules. Colors
shown are only to delineate compounds within the same row. 
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purified microtubules or on the microtubule cytoskeleton
of interphase cells (data not shown), mitotic cells treated
with this compound showed a shorter, disarrayed spindle
and misaligned chromosomes (Figure 6c,d) compared
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Figure 3
Chemical structures of small molecules that
directly affect the stability of microtubules
within cells. (a) Examples of compounds that
destabilize microtubules. (b) Compounds that
stabilize microtubules.
Figure 4
Dose response in A549 cells of small
molecules directly affecting the stability of
microtubules. (a) Treatment of cells with
nocodazole and taxol. (b) Treatment of cells
with 2b and 9a. Cells were treated for
22–24 h with compounds and a cytoblot
assay using the TG-3 mAb was performed as
described previously [8]. Results are depicted
as the mean value (n = 2 for compound 2b;
n = 4 for compound 9a, nocodazole, and
taxol) with standard deviations indicated with
bars. Data were normalized to a control
treatment with DMSO (0.5% v/v). The
concentration of each compound that caused
half the maximum increase in TG-3 reactivity
(EC50) was estimated from these graphs.
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with the normal bipolar spindle and alignment of chromo-
somes (Figure 6a,b). These results, and the results
described above, highlight the sensitivity of the mitotic
spindle and checkpoint to relatively weak perturbations
in microtubule dynamics that otherwise have no observ-
able effect on interphase cells [6,15]. Although this sensi-
tivity is remarkable, it is not unexpected given previous
work with low doses of vinca alkaloids and taxol [16].
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Figure 5
Interphase α-tubulin-staining patterns of
BS-C-1 kidney epithelial cells after treatment
with compounds that affect microtubule
stability. Cells were treated for 4 h with
(a,g) DMSO (0.1% v/v), (b) nocodazole
(10 µM), (c) Taxol (100 nM), (d) compound
2b (27 µM), (e,h) synstab A (25 µM) and for
(f) synstab A (30 µM for 2 h, then 2 h
recovery [following wash] without compound).
Cells were fixed, stained for α tubulin (green)
and chromatin (blue/purple), and fluorescence
microscopy was used to visualize the
distribution of microtubules. Treatment either
with nocodazole (b) or with compound 2b (d)
causes a loss of the normal microtubule
network. In contrast, treatment either with
taxol (c), or with synstab A (e,h), causes a
reversible (f), perinuclear accumulation of
microtubule bundles. Scale bars, ~25 µm.
Figure 6
Effect of a weak microtubule depolymerizer on
the mitotic spindle and chromosome
distribution. BS-C-1 cells were treated for 4 h
with DMSO (0.25 %) (a,b) or compound 2g
(49 µM) (c,d), fixed and stained for α-tubulin
(green), actin (red) and chromatin (blue).
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Group II: taxol-like small molecules that stabilize
microtubules
Compounds in group I share functional properties with
many synthetic compounds and natural products that
disrupt the interactions between the α/β tubulin subunits
of microtubules, whereas small molecules having the
opposite effect of stabilizing these interactions (e.g., taxol
[17], discodermolide [18,19]) are more rare [14,20]. On the
basis of the results from the visual assay of the effects of
compounds on the in vitro polymerization of purified
bovine brain tubulin (Figure 7), compound 9a (group II;
Figure 3b), here named synstab A (for synthetic stabi-
lizer), stabilizes microtubules polymerized from purified
bovine brain tubulin (Figure 7b), as does taxol (Figure 7c).
As a second means of confirming the stabilizing effects of
synstab A, we measured the change in the optical density
upon the polymerization of a solution of tubulin in the
presence of synstab A. In agreement with the visual assay,
the addition of an excess of synstab A (100 µM) increased
the rate and overall magnitude of the increase in optical
density because of polymer-dependent light scattering, as
compared with the addition of dimethyl sulfoxide
(DMSO; Figure 7d). Because this increase in optical
density reflects increased stability of microtubules in the
absence of microtubule-associated proteins and other cel-
lular factors, synstab A therefore stabilizes microtubules
through a direct interaction with tubulin proteins. 
To ensure that the observed increase in optical density was
because of the formation of microtubules and not other
structures, tubulin samples after polymerization were nega-
tively stained and visualized under low (× 4000) and high
magnification (× 50,000) using electron microscopy. As for
samples treated with taxol (data not shown), there was a
significant increase in the amount of microtubules
observed in the presence of synstab A (Figure 8a) relative
to treatment with DMSO (data not shown). Microtubules
that were formed showed a longitudinal axis of symmetry
and were of varying lengths. Under high magnification
(Figure 8b), striations indicative of protofilament bound-
aries were observed and the overall morphology was indis-
tinguishable from that of microtubules formed in the
presence of either taxol or DMSO (data not shown). Thus,
synstab A’s mechanism of microtubule stabilization in vitro
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Figure 7
Visual and quantitative assays of the effect of
synstab A on the polymerization of purified
bovine brain tubulin.  Representative fields of
view from fluorescence microscopy of
tetramethylrhodamine (TMR)-labeled tubulin
(green) samples treated with (a) DMSO
(0.22% v/v), (b) synstab A (22 µM) and (c)
taxol (22 µM). (d) The polymerization of
bovine brain tubulin was monitored by
measuring the time-dependent change in
optical density (absorbance units) at 340 nm
in the presence either of synstab A (100 µM;
blue) or of an equivalent concentration of
DMSO (1% v/v; purple). In the absence of
tubulin, the addition of synstab A alone
(green) to BRB80 buffer had no significant
effect over time. 
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does not involve a dramatic rearrangement of microtubule
structure, as might be expected to occur if it caused a non-
specific aggregation of tubulin.
In the cytoblot assay, synstab A had an EC50 of 10–15 µM
(Figure 4b), whereas a compound lacking the sulphonamide
group over a similar range of concentrations had no effect
(data not shown). The value of this cytoblot EC50 is
~500-fold greater than that observed with taxol (Figure 4a).
Consistent with the stabilizing effects of synstab A on puri-
fied microtubules (Figure 7), staining of kidney epithelial
cells (BS-C-1) showed that synstab A treatment leads to
microtubule bundles in interphase cells (Figure 5e,h) and to
disrupted spindles and abnormal chromosome distribution
in mitotic cells (data not shown). Testing of a series of
23 analogs of synstab A (Diverse E set, Chembridge Corp.),
up to concentrations of 100 µM, revealed a second, but
weaker compound (9b; Figure 3b) that caused similar phe-
notypic effects to those of synstab A (data not shown). The
analog of synstab A lacking the terminal sulphonamide
group, which had no effect on the in vitro polymerization of
tubulin, also had no observable effect on cells up to 100 µM
(data not shown). Because a 2 h treatment with synstab A
followed by its removal by washing restored the normal
microtubule staining pattern in both interphase (Figure 5f)
and mitotic (data not shown) cells, the observed effects of
synstab A are reversible and are not likely because of cova-
lent modification of tubulin. The reversible bundling of
interphase microtubules and the reversible effects on
mitotic cells are reminiscent of those in cells treated with
both discodermolide and taxol [19]. We note, however, that
the bundling of microtubules induced by taxol is less pro-
nounced than that induced by either synstab A in BS-C-1
cells or taxol in other cell lines (Figure 5c).
In agreement with the increased percentage of cells in
mitosis observed by fluorescence microscopy, fluores-
cence-activated cell sorting (FACS; Figure 9) confirmed
that, as with cells treated with nocodazole (Figure 9b) or
taxol (Figure 9c), cells treated with synstab A (Figure 9d)
had fully replicated chromosomes (4N DNA content)
and increased TG-3 staining. In addition, total cell
extracts derived from cells treated with taxol, or with
synstab A at concentrations that do not affect viability,
showed by immunoblotting increased TG-3-reactivity
(Figure 10). As shown in Figure 4b, treatment of cells
with synstab A at concentrations greater than 30 µM does
not result in a dose-dependent increase in TG-3 reactiv-
ity even though the maximum signal is less than that of
either taxol or nocodazole (Figure 4a). This suggests that
at high concentrations either synstab A is less effective at
inducing a mitotic arrest or it reduces cellular viability. In
support of the latter notion, treatment of cells with
synstab A for 24 h, but not with the analog lacking the
sulphonamide group, reduced the viability of A549 cells
by more than 80% at concentrations above 50 µM, as
measured by the reduction of the tetrazolium salt MTS
(data not shown). 
Taxol is thought to stabilize microtubules by counteracting
the effects of GTP hydrolysis through its binding to a glob-
ular domain on β tubulin [21]. To address whether synstab
A mimics the taxol mechanism of microtubule stabiliza-
tion, we determined whether synstab A could compete
with fluorescently labeled (Oregon Green) taxol (OGtx) for
binding to microtubules previously stabilized with guany-
lyl-α,β-methylene diphosphonate (GMPCPP, a non-
hydrolysable analogue of GTP). Using a fluorescent
microscopy assay, an equivalent concentration of DMSO
had no effect (Figure 11a), whereas synstab A displaced
OGtx from the microtubules when added at a concentra-
tion of 500 µM (Figure 11b). In the same assay, unlabeled
taxol caused a similar displacement when added at a con-
centration of 1 µM (data not shown). This mutually exclu-
sive binding of synstab A and OGtx is consistent with the
observed taxol-like effects of synstab A on cells
(Figure 5e,h), and suggests that the effects of synstab A are
either because it binds to the same or overlapping sites on
microtubules as taxol, or as a result of its ability to induce a
conformational change that prevents taxol binding.
Because the addition of synstab A did not decrease the sta-
bility of GMPCPP-stabilized microtubules (Figure 10d),
and because synstab A did not alter the overall microtubule
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Figure 8
Effect of synstab A on the in vitro polymerization of purified bovine
brain tubulin. Electron micrographs of negatively stained microtubules
formed in the presence of synstab A (100 µM). (a) Low magnification
(×4000), scale bar = 400 µm. (b) High magnification (×50,000), scale
bar = 200 µm.
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structure, as seen from the electron micrographs (Figure 8),
the displacement of OGtx by synstab A does not occur by
inhibiting formation of polymers to which taxol binds.
Given the similarities between the effects of synstab A and
taxol on cells, and synstab A’s ability to compete with taxol
for binding to microtubules, we next determined whether
synstab A treatment mimics other properties of known
microtubule stabilizers. Because taxol and discodermolide
prevent cold depolymerization of microtubules [19], we
tested whether treatment of cells with synstab A would
cause a similar effect. Although taxol treatment (10 µM,
4 h) noticeably stabilized microtubules, synstab A treat-
ment (25 µM, 4 h) only partially protected cells from cold
depolymerization (4°C, 0.5 h), resulting in a slight
increase in the number of remaining microtubules as com-
pared with untreated cells (data not shown). This suggests
that either synstab A stabilizes microtubules in a manner
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Figure 9
Cell-cycle distribution upon treatment of cells
with synstab A. Fluorescence-activated cell
sorting (FACS) analysis of A549 human lung
carcinoma cells treated for 22 h with (a) 0.2%
DMSO, (b) 332 nM nocodazole, (c) 2 µM
taxol or (d) 15 µM synstab A. Cells were
prepared for FACS analysis as described
previously [11] and the data were processed
using ModFiLT (V2.0). Depicted are the
relative number of cells, DNA content
measured from propidium iodide staining (2N
or 4N) and TG-3 mAb reactivity measured
through fluorescein-isothiocyanate labeling.
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different than that either of taxol or of discodermolide, or
that the stabilization of microtubules upon treatment with
synstab A is sufficient to perturb interphase and mitotic
microtubule dynamics, but not sufficient to counteract the
destabilizing effects of cold-induced depolymerization
due to differences in binding affinity or cell permeability. 
Group III: small molecules targeting mitotic machinery
other than tubulin
To begin to determine the mechanism of action of the 86
remaining group III compounds, each compound was
tested in a TG-3 cytoblot assay using cells that had previ-
ously been arrested in interphase by the histone deacety-
lase inhibitor trichostatin A [22] or the topoisomerase II
inhibitor ICRF-193 [23]. Under these conditions, none of
the group III compounds stimulated cells to accumulate in
mitosis, indicating that they require active cell-cycle pro-
gression to achieve their effects (data not shown).
Visual comparison of the chemical structures of group III
compounds to those of group I compounds revealed that
seven of 86 compounds show close structural homology to
compounds that act as destabilizers of purified tubulin
in vitro. Furthermore, although a number of these com-
pounds had no observable effect on interphase cells, the
effects of these compounds on microtubule organization
in mitotic cells are similar to those observed for known
weak microtubule depolymerizers (e.g., Figure 6c,d). This
suggests that a subset of compounds in group III are
likely to be weak microtubule destabilizers, ineffective at
destabilizing purified microtubules under the conditions
used to identify compounds in group I. 
As observed with the variation in strength of microtubule
depolymerization, the phenotype induced by many of the
group III compounds, in terms of chromosome distribution,
microtubule morphology and actin distribution in inter-
phase and mitotic cells, depended upon both the concen-
tration tested and duration of treatment. Treatment with 12
group III compounds at ~50 µM led to cell death or detach-
ment after 4 h; these compounds were not examined
further in this study. Given the similarity between aspects
of mitotic mechanisms and apoptosis, these compounds
may target components common to both pathways [24,25].
As a more stringent test of whether compounds had visible
effects on chromosomes and the cytoskeleton, cells were
treated for 4 h with of each of the remaining group III
compounds at ~100 µM. Under these conditions, 69 com-
pounds either had no observable effect on interphase cells
(although still increased the number of apparently normal
mitotic cells) or caused disorganization of otherwise
straight microtubules in interphase cells and partially or
completely disrupted spindles and chromosome distribu-
tion in mitotic cells. The compounds that produced the
latter effects may target cellular regulators of microtubule
dynamics, such as the centrosome that nucleates micro-
tubules or the microtubule-associated proteins that can
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Figure 10
Increased TG-3 reactivity upon treatment of cells with synstab A. A549
cells were treated for 22 h with 0.2% DMSO (Nt), 12 µM aphidicolin
(Aph), 332 nM nocodazole (Noc), 2 µM taxol (Tax) or synstab A, as
indicated (in micromolar). Equivalent amounts of total cell extract were
immunoblotted using the TG-3 mAb. Molecular weight standards
shown are in kDa. The high-molecular weight proteins, other than
nucleolin (105 kDa), that show increased detection with TG-3 upon
treatment with nocodazole, taxol and synstab A remain unknown.
Figure 11
Mutually exclusive binding of synstab A and taxol to bovine brain
microtubules. Fluorescence microscopy was used to visualize the
binding of an Oregon-Green-labeled taxol derivative (OGtx) to TMR-
labeled (red), GMPCPP-stabilized microtubules. When incubated in
the presence of 5% DMSO, but in absence of a competitor, the
OGtx signal (a) colocalizes with the TMR signal from microtubules (c).
In contrast, when incubated in the presence of synstab A (500 µM),
the OGtx signal (b) does not colocalize with the TMR signal from
microtubules (d). 
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either stabilize or destabilize microtubules in cells [26].
The similarity in phenotype of these compounds to weak
destabilizers, however, makes it difficult to determine
their mechanism of action without further tests of resyn-
thesized compounds. In general, those compounds that
increased the number of cells in mitosis without an
obvious morphological effect did so weakly, even at high
concentrations, compared with compounds that were
found to directly target microtubules (e.g., Figure 3).
These compounds may affect the activity of cell-cycle reg-
ulators, the activity of which is required for exit from
mitosis (e.g., the activity of the anaphase-promoting
complex CDC5,14,15,20) [27]. On the basis of the localiza-
tion of MAD2 and the phosphorylation status of the kine-
tochore (the macromolecular structures that links mitotic
chromosomes to microtubules) epitope 3F3 [28], it should
be possible, in future studies, to determine whether the
action of these compounds involves the activation of the
spindle assembly checkpoint or some other mechanism. 
From fluorescence microscopy of cells stained for micro-
tubules, chromatin and actin, the remaining five compounds
(10–14; Figure 12) were determined to be mitosis specific.
Phenotypically, all five compounds had no observable
effect upon interphase cells, but disrupted mitotic spindle
morphology, altered chromosome distribution, or both, in
mitotic cells. As discussed by Mayer et al. [29], the unique
monopolar phenotype of one of these compounds (10,
named monastrol) led to the discovery that monastrol
specifically inhibits the kinesin-related protein Eg5. Treat-
ment of BS-C-1 cells with compound 11 caused a similar
monopolar phenotype as monastrol (data not shown), sug-
gesting that 11 targets Eg5 or another component of the
pathway required for spindle bipolarity. The cellular
targets of the remaining three compounds remain
unknown. In support of the hypothesis that each of these
compounds target different components of the mitotic
machinery, the phenotypic effects upon treatment of cells
with these compounds were each distinct (Figure 13). For
example, treatment with compound 12 (Figure 13b) caused
the formation of a double spindle and minor chromosome
misalignment, whereas compound 14 had no apparent
effect on the mitotic spindle but caused severe chromo-
some misalignment (Figure 13c). This later phenotype
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Figure 12
Chemical structures of mitosis-specific small-
molecule inhibitors that do not interact directly
with microtubules and have no observable
morphological effect on the cytoskeleton or
chromatin of interphase cells. Compound 10
(monastrol) is an inhibitor of the kinesin-related
motor protein Eg5 [29]. The cellular targets of
compounds 11–14 remain unknown.
Figure 13
Example of mitotic abnormalities induced by
compounds that have no observable effect on
interphase cellular morphology or chromatin
distribution. BS-C-1 kidney epithelial cells
were treated for 4 h with (a) DMSO
(0.1%v/v), (b) compound 10 (70 µM) and
(c) compound 14 (70 µM) and stained for
α tubulin (green) and chromatin (blue). Scale
bar, ~15 µm.
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suggests that compound 14 may target a component of the
kinetochore and thereby prevent the alignment of chromo-
somes at the metaphase plate. 
Future directions and challenges
Since the first description in 1889 of the effects of
colchicine on mitosis, small molecules have played an
essential role in the dissecting of the molecular mecha-
nisms of chromosome segregation [30]. Future work from
this screen will be aimed at the identification of the cellu-
lar targets of compounds 11–14 using biochemical or
genetic methods. The success of the first approach is
dependent upon both the specificity of the compound and
the affinity, whereas the success of the latter approach
depends on specificity and on the availability of existing
mutant phenotypes to match observed phenotypic
defects. In this regard, comparison of the effects of these
compounds to known mutants of yeast and to developing
embryos of the nematode Caenorhabditis elegans may
provide a means either of identifying the exact target or of
suggesting a mechanism of action [31]. This comparison
can be based upon the observation of cellular morphology,
the use of DNA microarrays and proteome-wide analysis.
One of the main challenges in high-throughput screening
is to obtain the largest amount of useful information while
using the smallest amount of compound. In this regard, a
negative result obtained with a compound in one assay
may be highly instructive in the context of another assay.
Often the amount of compound available to validate
whether its mechanism is distinct from previously known
compounds is limited. In the case at hand, our ability to
assess with a small amount of compound whether com-
pounds targeted tubulin directly, using purified tubulin
from bovine brain, was instrumental to the identification
of compounds affecting the mitotic machinery through
novel mechanisms.
Significance
Although the discovery of small-molecule inhibitors of
protein–protein interactions is generally demanding, we
noted the significant occurrence (~0.3% of compounds
screened) of direct inhibitors of α/β tubulin interactions
in this study. This illustrates the use of a system-based,
phenotype-directed screen to identify components in a
pathway that are most easily targeted by small mol-
ecules. It also suggests that the toxicity associated with
many compounds may be due to their ability to destabi-
lize microtubules. Small molecules capable of stabilizing
protein–protein interactions are of interest both from the
perspective of understanding the molecular basis of
protein–protein interactions and in the specific case of
α/β tubulin, because of the demonstrated use of taxol as
an anticancer agent. Although synstab A shares many of
the functional properties of taxol, it does not share struc-
tural features of known stabilizers of microtubules both
natural (taxoids, discodermolide, epothilone and
eleutherobin) and synthetic (e.g., GS-164 [32]). The ease
with which synstab A was identified and its simple struc-
ture suggests to us that screening-based approaches to
the discovery of taxol-like compounds will prove more
effective than design-based approaches using ‘pharma-
cophore’ models [33,34]. In the context of other complex
cellular processes, these results suggests that cell-based
assays, initially using an antibody to select for small-mol-
ecule-induced post-translational modifications, in con-
junction with directed cytology and in vitro assays, will
provide a fruitful means of exploring many biological
processes. 
Materials and methods 
Cell cultures
A549 (human, lung carcinoma) and BS-C-1 (African green monkey,
kidney epithelial) cells were maintained at 37°C with 5% CO2 in Dulbe-
co’s modified eagle medium containing 10% fetal bovine serum,
100 units/ml penicillin G sodium, 100 µg/ml streptomycin sulphate and
2 mM glutamine (DMEM+; GibcoBRL). 
TG-3 cytoblot assay
Cells were seeded in 50 µl of DMEM+ at a density of 4,000 cells per
well of 384-well assay plates (Nalge Nunc, white, tissue culture
treated) and cultured for 12 h at 37°C with 5% CO2. Library com-
pounds (Diverse E set, Chembridge Corp.) dissolved in DMSO
(5 mg/ml) were arrayed in 384-well plates and 50–200 nl of each com-
pound was pin-transferred into 384-well assay plates. After 22–24 h,
the percentage of cells in mitosis was assayed using the TG-3 mAb
(11–13) as described [9]. Data were collected on an Analyst plate
reader (LJL Biosystems) with 0.2 s integration time. After two rounds of
screening, compounds that increased TG-3 reactivity by 2.5 times or
greater than control cells treated with DMSO were chosen for further
analysis. To test for the requirement of active cell-cycle progression,
cells were pretreated for 4 h, with either 300 nM trichostatin or 14 µM
ICRF-193, and group III compounds were added to a final concentra-
tion of ~50 µM. After 16–18 h, a TG-3 cytoblot assay was performed. 
In vitro tubulin polymerization and taxol competition assays
Purification of bovine tubulin and labeling of tubulin with tetramethyl-
rhodamine (TMR) or Oregon Green (OG) fluorescent dye were per-
formed as described [35] (see also http://iccbweb.med.harvard.edu/
mitchisonlab/Pages/tubprep.html for more details). The extent of micro-
tubule polymerization was determined in the presence of each com-
pound at ~50 µM using a standard in vitro tubulin polymerization assay
(see http://iccbweb.med.harvard.edu/mitchisonlab/Pages/poly.html for
more details). After incubation for 20 min at 37°C, samples of reactions
were spotted on a glass slide and the extent of tubulin polymerization
was visually assessed using fluorescence microscopy of OG-labeled
microtubules. To quantitatively assess the effect of synstab A on the
dynamics of microtubule polymerization, either synstab A (100 µM), or
an equivalent concentrations of DMSO, was added to 10 µM tubulin
and incubated at 37°C, in the presence of 1 mM GTP, in degassed
PEM buffer (80 mM PIPES, pH 6.9, 1 mM EGTA, 1 mM MgCl2). After
2 min, the optical density of the sample (340 nm) was measured at 30 s
intervals using a Hewlett Packard 8452A diode array spectrophotome-
ter. For competition experiments between synstab A and taxol, 500 µM
synstab A, or an equivalent concentration of DMSO (5%), was added to
TMR-labeled, GMPCPP-stabilized microtubules (400 nM) in PEM buffer
containing 240 nM of a fluorescently labeled (OG) taxol derivative
(OGtx) (RF, unpublished results). Following incubation at room tempera-
ture for 10 min, 1.5 µl samples of each reaction were spotted onto a
glass slide, covered with a coverslip and the localization of OGtx to the
GMPCPP-stabilized, TMR-labeled microtubules was visualized using a
Research Paper  Small-molecule inhibition of mitosis Haggarty et al. 285
cm7405.qxd  03/22/2000  08:30  Page 285
Nikon E-800 fluorescence microscope. Control treatments in the
absence of DMSO showed OGtx staining of TMR-labeled microtubules,
whereas the addition of 1 µM unlabeled taxol prevented the co-localiza-
tion of OGtx to TMR-labeled microtubules. 
Immunofluorescence and negative stain electron microscopy
BS-C-1 cells were seeded on glass coverslips at 80–90% confluency
and compounds in DMSO were added to final concentrations as indi-
cated. Cells were fixed with 0.2% glutaraldehyde and then stained for
microtubules with an anti-α-tubulin antibody (Sigma), for chromatin with
Hoecsht 33342 dye (Molecular Probes), and for actin with tetramethyl
rhodamine isothiocyanate-conjugated phalloidin (Sigma). Images were
obtained using a Nikon E-800 or Leitz microscope. For electron
microscopy of microtubules, samples of tubulin after polymerization in
the presence of either synstab A (100 µM) or an equivalent concentra-
tion of DMSO were spotted on to carbon-coated copper grids
(200 mesh) and negatively stained for 1 min with 0.5% (w/v) uranyl
acetate. After washing with 5 mM EGTA, images were obtained under
low (× 4000) and high magnification (× 50,000).
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